StreetInsider.com Pre-Open Movers:

Avanir Pharmaceuticals (NASDAQ: AVNR) 125% HIGHER; announced positive top-line results from the company's Phase III clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE